how long have glp-1 drugs been on the market GLP-1s and Unintended Consequences of the $100 Billion GLP-1 Receptor Agonist Market Size,

Rosenfeld RG, Pham H, Keller BT, Borchardt RT, Pardridge WM: Demonstration and structural comparison of receptors for insulin-like growth factor-I and -II (IGF-I and -II) in brain and bloodbrain barrier

At the same time, many clinical trials have shown the effectiveness of l-carnitine in relieving fatigue caused by the treatment of diseases such as cancer, MS, and many other diseases

Trends Mol Med 29(4):315328 Hall B, Levy S, Dufault-Thompson K, Arp G, Zhong A, Ndjite GM, Weiss A, Braccia D, Jenkins C, Grant MR, Abeysinghe S (2024) Bilr is a gut microbial enzyme that reduces bilirubin to urobilinogen

Alterations of the gut microbiome and TMAO levels in patients with ulcerative colitis

Traditional sleep medications have defined indications, known risks, and established prescribing guidelines

It is estimated that between 1% and 6% of the population have a congenital melanocytic nevus (CMN)